Gypenoside XVII regulates apoptosis and fear extinction deficits mediated by post-traumatic stress disorder through the PERK/CHOP signaling pathway
European Journal of Pharmacology · 2025
DOI: 10.1016/j.ejphar.2025.178391 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2025. Verfasst von Yitai Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Neurological Disease Center, Characteristic Medical Center of People's Armed Police Forces, Tianjin, 300162, China; Tianjin University of Traditional…. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Apoptosis, eIF-2 Kinase, Transcription Factor CHOP. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
OBJECTIVE: Post-traumatic stress disorder (PTSD) leads to apoptosis in the medial prefrontal cortex (mPFC). Although studies have demonstrated the neuroprotective effects of Gypenoside XVII(GP-17), the potential mechanisms of GP-17 for the treatment of PTSD remain to be elucidated. This study aimed to investigate the inhibitory effect of GP-17 on the fear state of PTSD through the PERK/CHOP pathway. MATERIALS AND METHODS: Establishment of a Single Prolonged Stress (SPS) model using Sprague Dawley (SD) rats, combined with behavioral assessments, TUNEL staining, Western blot analysis, Immunofluorescence staining, and Flow cytometry analyses of a primary microglia model. This study aims to evaluate the effects of GP-17 treatment on fear and anxiety states, as well as the role of the endoplasmic reticulum (ER) stress signaling pathway, specifically protein kinase RNA (PKR)-like ER kinase (PERK), in regulating apoptosis in rats. RESULTS: Research shows that GP-17 significantly reduces apoptosis in the prefrontal cortical microglia of SPS rats by modulating the PERK-C/EBP-homologous protein (CHOP) signaling pathway. This modulation helps improve fear extinction deficits and reduces anxiety-like behavior. Additionally, GP-17 intervention effectively inhibits neuroinflammation and oxidative stress. In vitro experiments further demonstrate that GP-17 prevents tunicamycin (Tu)-induced apoptosis related to PERK-mediated ER stress in primary rat microglia. CONCLUSION: GP-17 demonstrates therapeutic potential for PTSD by modulating fear and anxiety in SPS rats through the PERK/CHOP pathway, positioning it as a promising candidate for PTSD treatment via the endoplasmic reticulum stress pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neurological Disease Center, Characteristic Medical Center of People's Armed Police Forces, Tianjin, 300162, China; Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China.
- Neurological Disease Center, Characteristic Medical Center of People's Armed Police Forces, Tianjin, 300162, China.
- Neurological Disease Center, Characteristic Medical Center of People's Armed Police Forces, Tianjin, 300162, China; Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China. Electronic address: sunht20…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Y., Wang, J., Wang, S., Chen, Y., Li, Z., Zhang, H., Zhou, P., Li, W., Ren, D., & Sun, H. (2025). Gypenoside XVII regulates apoptosis and fear extinction deficits mediated by post-traumatic stress disorder through the PERK/CHOP signaling pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178391
Vancouver
Yang Y, Wang J, Wang S, Chen Y, Li Z, Zhang H, et al. Gypenoside XVII regulates apoptosis and fear extinction deficits mediated by post-traumatic stress disorder through the PERK/CHOP signaling pathway. European Journal of Pharmacology. 2025. doi:10.1016/j.ejphar.2025.178391
BibTeX
@article{Yang2025,
author = {Yang, Yitai and Wang, Jingjing and Wang, Shuying and Chen, Yueyang and Li, Zemeng and Zhang, Huimin and Zhou, Pengbo and Li, Wei and Ren, Dangli and Sun, Hongtao},
title = {Gypenoside XVII regulates apoptosis and fear extinction deficits mediated by post-traumatic stress disorder through the PERK/CHOP signaling pathway},
journal = {European Journal of Pharmacology},
year = {2025},
doi = {10.1016/j.ejphar.2025.178391}
}
EUVIMED